MONUROL Side Effects

6656198-8 | Aggression, Dyspnoea, Headache, Hypoglycaemia, Hypothyroidism, Malaise, Pruritus, Urticaria
on Mar 26, 2010 Female patient from UNITED STATES , 83 years of age, weighting 140.0 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Monurol (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, dyspnoea, headache (What is headache?), hypoglycaemia, hypothyroidism, malaise, pruritus, urticaria. Monurol dosage: Three Once Daily For 3 D Po. During the same period patient was treated with CIPRO (One Daily Po) (View Cipro Review and Cipro Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

6278707-3 | Arterial Disorder, Chest Pain, Hypoaesthesia, Pain In Extremity
Patient was taking Monurol (View Usage). Patient had the following side effects: arterial disorder, chest pain (What is chest pain?), hypoaesthesia, pain in extremity on Jul 16, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Monurol dosage: (3 Gm, Once), Oral. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6195287-1 | Arterial Disorder, Chest Pain, Hypoaesthesia
Adverse event was reported on May 12, 2009 by a Female patient taking Monurol (View Usage) (Dosage: (3 Gm, Once), Oral) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 70 years of age, After Monurol was administered, patient had the following side effects: arterial disorder, chest pain (What is chest pain?), hypoaesthesia. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6062684-4 | Loss Of Consciousness, Nausea, Swelling, Urticaria
on Jan 19, 2009 Female patient from ITALY , 63 years of age, weighting 176.4 lb, was diagnosed with immunisation and was treated with Monurol (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, nausea (What is nausea?), swelling, urticaria. Monurol dosage: (2 Gm,once),oral. During the same period patient was treated with FLUIDASA(CAPSULES) ((once),oral) (View Fluidasa(capsules) Review and Fluidasa(capsules) Label ), VACUNA ANTIGRIPAL PASTEUR (0.5 MILLILITRE(S)) (0.5 Ml (0.5 Ml,once),intramuscular) (View Vacuna Antigripal Pasteur (0.5 Millilitre(s)) Review and Vacuna Antigripal Pasteur (0.5 Millilitre(s)) Label ).


6023452-2 | Loss Of Consciousness, Nausea, Swelling, Urticaria
on Dec 09, 2008 Female patient from ITALY , 63 years of age, was diagnosed with nasopharyngitis, immunisation and was treated with Monurol (View Usage). Patient had the following side effects: loss of consciousness, nausea (What is nausea?), swelling, urticaria. Monurol dosage: 2 Gm, Once, Oral. During the same period patient was treated with FLUIDASA ((once), Oral) (View Fluidasa Review and Fluidasa Label ), VACUNA ANTIGRIPAL PASTEUR (0.5 Ml (0.5 Ml, Once), Intramuscular) (View Vacuna Antigripal Pasteur Review and Vacuna Antigripal Pasteur Label ).

5739696-0 | Facial Bones Fracture, Fall, Syncope, Vomiting
Patient was taking Monurol (View Usage). After Monurol was administered, patient had the following side effects: facial bones fracture, fall (What is fall?), syncope, vomiting on Apr 24, 2008 from ITALY Additional patient health information: Male patient , 66 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Monurol dosage: 6 G Once Po. Patient was hospitalized.

5712006-0 | Micturition Disorder, Urine Output Decreased, Urine Output Increased
Adverse event was reported on Apr 03, 2008 by a Male patient taking Monurol (View Usage) (Dosage: 3 G Once Po) was diagnosed with cystitis and. Location: ITALY , 71 years of age, Patient experienced the following unwanted or unexpected effects: micturition disorder, urine output decreased, urine output increased.

5633730-4 | Facial Bones Fracture, Fall, Injury, Syncope, Vomiting
on Feb 01, 2008 Male patient from ITALY , 66 years of age, was treated with Monurol (View Usage). Patient had the following side effects: facial bones fracture, fall (What is fall?), injury, syncope, vomiting. Monurol dosage: 6 G Once Po. Patient was hospitalized.

5605899-9 | Blood Creatinine Increased, Blood Potassium Increased, Bundle Branch Block Left, Renal Failure
on Jan 11, 2008 Female patient from FRANCE , 94 years of age, weighting 154.3 lb, was treated with Monurol (View Usage). After Monurol was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, bundle branch block left, renal failure. Monurol dosage: 3 G Po. During the same period patient was treated with PRETERAX (View Preterax Review and Preterax Label ), IPERTEN (MANIDIPINE HYDROCHLORIDE) (View Iperten (manidipine Hydrochloride) Review and Iperten (manidipine Hydrochloride) Label ), TEMERIT (NEBIVOLOL) (View Temerit (nebivolol) Review and Temerit (nebivolol) Label ), LASIX (20 Mg) (View Lasix Review and Lasix Label ), MEDIATENSYL (URAPIDIL) (View Mediatensyl (urapidil) Review and Mediatensyl (urapidil) Label ), DISCOTRINE (GLYCERYL TRINITRATE) (View Discotrine (glyceryl Trinitrate) Review and Discotrine (glyceryl Trinitrate) Label ), PLAVIX (View Plavix Review and Plavix Label ), VASTAREL (TRIMETAZIDINE) (35 Mg Qd Po) (View Vastarel (trimetazidine) Review and Vastarel (trimetazidine) Label ). Patient was hospitalized.

5584633-5 | Blood Potassium Increased, Bundle Branch Block Left, Renal Failure
Patient was taking Monurol (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, bundle branch block left, renal failure on Dec 20, 2007 from FRANCE Additional patient health information: Female patient , 94 years of age, weighting 154.3 lb, . Monurol dosage: 3 Mg Po. During the same period patient was treated with IRBESARTAN (150 Mg Po) (View Irbesartan Review and Irbesartan Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), IPERTEN (MANIDIPINE HYDROCHLORIDE) (View Iperten (manidipine Hydrochloride) Review and Iperten (manidipine Hydrochloride) Label ), TEMERIT (NEBIVOLOL) (View Temerit (nebivolol) Review and Temerit (nebivolol) Label ), LASLILIX (FUROSEMIDE) (20 Mg) (View Laslilix (furosemide) Review and Laslilix (furosemide) Label ), MEDIATENSYL (URAPIDIL) (View Mediatensyl (urapidil) Review and Mediatensyl (urapidil) Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5546822-5 | Cyanosis, Dyspnoea
Adverse event was reported on Nov 21, 2007 by a Female patient taking Monurol (View Usage) (Dosage: 3 G Once Po) was diagnosed with cystitis and. Location: ITALY , 74 years of age, Patient had the following side effects: cyanosis, dyspnoea. During the same period patient was treated with ORAL ANTIDIABETICS (View Oral Antidiabetics Review and Oral Antidiabetics Label ), HYPOTENSIVE AGENTS (NOS) (View Hypotensive Agents (nos) Review and Hypotensive Agents (nos) Label ), CARDIOPROTECTIVE AGENTS (NOS) (View Cardioprotective Agents (nos) Review and Cardioprotective Agents (nos) Label ). Patient was hospitalized.

5533935-7 | Blood Creatinine Increased, Blood Potassium Increased, Bundle Branch Block Left, Electrocardiogram P Wave Abnormal, Renal Failure
on Nov 13, 2007 Female patient from ITALY , 94 years of age, weighting 154.3 lb, was treated with Monurol (View Usage). After Monurol was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, bundle branch block left, electrocardiogram p wave abnormal, renal failure. Monurol dosage: 3 G Unk Po. During the same period patient was treated with IRBESARTAN (150 Mg Unk Po) (View Irbesartan Review and Irbesartan Label ), PRETERAX (View Preterax Review and Preterax Label ), IPERTEN (MANIDIPINE HYDROCHLORIDE) (View Iperten (manidipine Hydrochloride) Review and Iperten (manidipine Hydrochloride) Label ), TEMERIT (NEBIVOLOL) (View Temerit (nebivolol) Review and Temerit (nebivolol) Label ), LASIX (20 Mg Unk) (View Lasix Review and Lasix Label ), MEDIATENSYL (URAPIDIL) (View Mediatensyl (urapidil) Review and Mediatensyl (urapidil) Label ), DISCOTRINE (GLYERCYL TRINITRATE) (View Discotrine (glyercyl Trinitrate) Review and Discotrine (glyercyl Trinitrate) Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5243285-4 | Clostridium Difficile Colitis, Pseudomembranous Colitis
on Feb 02, 2007 Female patient from POLAND , 75 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Monurol (View Usage). Patient experienced the following unwanted or unexpected effects: clostridium difficile colitis, pseudomembranous colitis. Monurol dosage: 3 G Once Po.

5167227-5 | Abasia, Arthralgia, Coordination Abnormal, Impaired Driving Ability, Leukocytoclastic Vasculitis, Vascular Purpura
Patient was taking Monurol (View Usage). Patient had the following side effects: abasia, arthralgia, coordination abnormal, impaired driving ability, leukocytoclastic vasculitis, vascular purpura on Nov 16, 2006 from FRANCE Additional patient health information: Female patient , 23 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Monurol dosage: 3 G Once; Po. Patient was hospitalized and became disabled.

5128205-5 | Arthritis, Vascular Purpura, Walking Aid User
Adverse event was reported on Sep 26, 2006 by a Female patient taking Monurol (View Usage) (Dosage: 3 G Once Po) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 23 years of age, After Monurol was administered, patient had the following side effects: arthritis (What is arthritis?), vascular purpura, walking aid user.

5128204-3 | Anaphylactic Reaction
on Sep 25, 2006 Female patient from ITALY , 52 years of age, was treated with Monurol (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Monurol dosage: 3 G Once Po. Patient was hospitalized.

5097769-2 | Hepatitis
on Aug 21, 2006 Male patient from SPAIN , 53 years of age, was diagnosed with cystitis and was treated with Monurol (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Monurol dosage: 3 G Qd Po. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PLAVIX (View Plavix Review and Plavix Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ).

4951511-1 | Haematuria
Patient was taking Monurol (View Usage). After Monurol was administered, patient had the following side effects: haematuria on Feb 04, 2005 from UNITED STATES Additional patient health information: Female patient , 75 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Monurol dosage: 3 G Once Po. During the same period patient was treated with MANDELIC ACID (View Mandelic Acid Review and Mandelic Acid Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), RIMANTADINE HCL (View Rimantadine Hcl Review and Rimantadine Hcl Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

4819857-5 | Anaphylactic Reaction
Adverse event was reported on Oct 18, 2005 by a Female patient taking Monurol (View Usage) (Dosage: 3 G Once Po) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: INDONESIA , 24 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Patient was hospitalized.

4816410-4 | Clostridium Colitis, Disease Recurrence
on Oct 25, 2005 Female patient from FRANCE , 73 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Monurol (View Usage). Patient had the following side effects: clostridium colitis, disease recurrence. Monurol dosage: 3 G Once Po. During the same period patient was treated with PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), THEOSTAT (THEOPHYLLINE) (View Theostat (theophylline) Review and Theostat (theophylline) Label ), ULTRALEVURE (SACCHAROMYCES BOULARDII) (View Ultralevure (saccharomyces Boulardii) Review and Ultralevure (saccharomyces Boulardii) Label ), SMECTA (View Smecta Review and Smecta Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ). Patient was hospitalized.

4768979-6 | Clostridium Colitis
on Jul 27, 2005 Female patient from FRANCE , 73 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Monurol (View Usage). After Monurol was administered, patient had the following side effects: clostridium colitis. Monurol dosage: 3 G Once Po. During the same period patient was treated with PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), THEOSTAT (THEOPHYLLINE) (View Theostat (theophylline) Review and Theostat (theophylline) Label ), ULTRALEVURE (SACCHAROMYCES BOULARDII) (View Ultralevure (saccharomyces Boulardii) Review and Ultralevure (saccharomyces Boulardii) Label ), SMECTA (View Smecta Review and Smecta Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ). Patient was hospitalized.

4766365-6 | Hypokalaemia, Inflammation, Rash Maculo-papular, Toxic Skin Eruption
Patient was taking Monurol (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, inflammation, rash maculo-papular, toxic skin eruption on Aug 24, 2005 from BELGIUM Additional patient health information: Female patient , 75 years of age, . Monurol dosage: 3 G Once, Po. During the same period patient was treated with XANITOL LUTEINE (View Xanitol Luteine Review and Xanitol Luteine Label ), ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OROFAR (BENZOXONIUM CHLORIDE) (View Orofar (benzoxonium Chloride) Review and Orofar (benzoxonium Chloride) Label ), LORAMET (LORMETAZEPAM) (View Loramet (lormetazepam) Review and Loramet (lormetazepam) Label ), QUINTEX (View Quintex Review and Quintex Label ), MICONAZOLE NITRATE (View Miconazole Nitrate Review and Miconazole Nitrate Label ). Patient was hospitalized.

4724910-0 | Clostridium Colitis
Adverse event was reported on Jul 07, 2005 by a Female patient taking Monurol (View Usage) (Dosage: 3 G Once Po) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 71 years of age, Patient had the following side effects: clostridium colitis. During the same period patient was treated with PREVISCAN (FLUINDIONE) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), THEOSTAT (THEOPHYLLINE) (View Theostat (theophylline) Review and Theostat (theophylline) Label ), ULTRALEVURE (SACCHAROMYCES BOULARDII) (View Ultralevure (saccharomyces Boulardii) Review and Ultralevure (saccharomyces Boulardii) Label ), SMECTA (View Smecta Review and Smecta Label ). Patient was hospitalized.

4610824-3 | Diarrhoea, Dizziness
on Jun 22, 2004 Female patient from , 75 years of age, was diagnosed with cystitis and was treated with Monurol (View Usage). After Monurol was administered, patient had the following side effects: diarrhoea, dizziness (What is dizziness?). Monurol dosage: 3 Mg Once Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ECOTRIN (ACETYLSALICYCLIC ACID) (View Ecotrin (acetylsalicyclic Acid) Review and Ecotrin (acetylsalicyclic Acid) Label ). Patient was hospitalized.